RE/MAX Holdings, Inc. (RMAX)
NYSEReal EstateReal Estate - ServicesSnapshot 2026-09-04
$12.36-9.25%
Close 2026-08-24 · 1-day change
NYSEReal EstateReal Estate - ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · RMAX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $12 RMAX trades at 11× p/e, below its 20× p/e peer median. Our $21 fair value sits well above the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $17.56 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $42.45 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $19.80 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $64.69 | 29.0 | 2.87 | TTM | high |
| Peer P/FCF | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Not enough peers to compare yet.
Self-history needs ~20 months of data.
Trailing four: 2018-Q3, 2020-Q1, 2020-Q2, 2020-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $14.56 |
| 10.0 |
| 1.46 |
| TTM |
| high |
| Peer P/E | 12M | $21.29 | 19.7 | 1.08 | TTM | high |
| Peer P/S | 12M | $15.44 | 1.0 | 16.00 | TTM | high |
| triangulated | 12M | $22.83 | 19.7 | 1.16 | Triangulated | high |
| Peer P/FCF | 3Y | $13.52 | 10.0 | 1.36 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $27.66 | 19.7 | 1.40 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $16.78 | 1.0 | 17.39 | guidance | medium |
| Peer P/FCF | 5Y | $12.86 | 10.0 | 1.29 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $30.02 | 19.7 | 1.52 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $18.22 | 1.0 | 18.88 | guidance | medium |